Longeveron Inc. logo

Longeveron Inc.

NASDAQ:LGVN

Overview | Financials
Company Name Longeveron Inc.
Symbol LGVN
Currency USD
Price 3.25
Market Cap 31,202,971
Dividend Yield 0%
52-week-range 0.771 - 36.5
Industry Biotechnology
Sector Healthcare
CEO Mr. Mohamed Wa'el Ahmed Hashad
Website https://www.longeveron.com

An error occurred while fetching data.

About Longeveron Inc.

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase

Related Stocks

Biomea Fusion, Inc. logo

Biomea Fusion, Inc.

BMEA

5.16 USD

Chimerix, Inc. logo

Chimerix, Inc.

CMRX

0.9 USD

Harvard Bioscience, Inc. logo

Harvard Bioscience, Inc.

HBIO

3.18 USD

OptiNose, Inc. logo

OptiNose, Inc.

OPTN

1.08 USD

Inozyme Pharma, Inc. logo

Inozyme Pharma, Inc.

INZY

5.32 USD

Omeros Corporation logo

Omeros Corporation

OMER

4.88 USD

High Tide Inc. logo

High Tide Inc.

HITI

1.83 USD

Financials

Numbers are in millions USD

Numbers are in millions USD